Cookies need to be enabled on your browser for this site to work properly. Please enable cookies before proceeding.More details
This site is optimized for Firefox (v1.x), Internet Explorer (v6.x), Chrome (v0.x), Safari (v3.x) and Netscape (v7.x) on Windows and Firefox (v1.x), Netscape (v7.x) and Safari (1.3) on the Macintosh.More details
JavaScript needs to be enabled on your browser for this site to work properly. Please enable JavaScript before proceeding.More details
 
Contact Us|Help 
LOGIN HERE[REGISTER]
Remember Me
 
E-mail to colleaguePrint-friendly page
Novartis drug Afinitor®; approved by FDA as first medication for children and adults with a benign brain tumor associated with tuberous sclerosis [Source: Novartis ]
(2)(1)(1)
[30-Oct-2010] Novartis announced that the US Food and Drug Administration (FDA) has approved Afinitor®; (everolimus) tablets for patients with subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS), who require therapeutic intervention but are not candidates for curative surgical resection. Available material includes soundbites.
Useful Links/Documents
Novartis
Media releases
Press releasePDF
    Page 1 of 1    
Vicky Whittemore, PhD and Kari Luther Rosbeck: TS Alliance (Source: Novartis)
Soundbites from Vicky Whittemore, PhD and Kari Luther Rosbeck: TS Alliance
TRT:00:04:27More
Debora Moritz, Mother of SEGA Patient (Source: Novartis)
Soundbites from Debora Moritz, Mother of SEGA Patient
TRT:00:05:15More